ArticleZeitschrift fur Rheumatologie2020

Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.

G G Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.